Fluid ORiented Therapy for yoUNg Asa 1patients

Not Applicable

Completed

• Conditions: Hemodynamics
• Interventions: Device: FloTrac

• Registration Number: NCT03090399
• Lead Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Brief Summary

In this retrospective analysis investigators will study the effects of using a minimally invasive hemodynamic monitoring (FloTrac-Edwards) on postoperative outcomes. Participants will compare a control group to a case group; in both groups ASA 1 patients suffering from advanced ovarian cancer underwent radical cytoreductive surgery. In case group hemodynamic was managed by using the FloTrac system; in the control group a standard hemodynamic monitoring was used.

Detailed Description

Not available

Study Timeline

• Study Start: 2012-01
• Primary Completion: 2015-07
• Study Completion: 2017-01
• Study First Submitted: 2017-01-13
• Status Verified: 2017-03
• Study First Submitted QC: 2017-03-20
• Last Update Submitted: 2017-03-20
• Study First Posted: 2017-03-24
• Last Update Posted: 2017-03-24

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 60

Inclusion Criteria

• ASA 1

Exclusion Criteria

• cardiac diseases
• pulmonary diseases
• renal diseases
• metabolic disorders

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
case group	FloTrac	patients in which fluids were administered according to FloTrac parameters

Primary Outcome Measures

Name	Time	Method
prevalence of complications	up to 30 days

Secondary Outcome Measures

Name	Time	Method
days of hospitalization	up to 12 weeks